Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Jacques Chitte who wrote (3498)	4/20/1998 9:32:00 PM
From: Doug Shapiro	Read Replies (1) \| Respond to of 7041

You may have hit the nail on the head this stock is shadowing PFE waiting for the first word of ineffectual results or strange side effects. My question is what formulation of phentolamine will be available at the pharmacy? Will it only be the quick dissolving formulation that is patented? Can the druggist mix up some liquid phentolamine to put in your juice? What is to prevent any other generic drug company from selling phentolamine at a fraction of the price of a Vasomax pill? Anyone?

To: Jacques Chitte who wrote (3498)	4/20/1998 9:43:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

If Vasomax doesn't WORK, then the stock will also become worthless eventually. I don't think the Street's enthusiasm for sexy drugs will last through that. Even if FDA approves Vasomax, and I think that's unlikely, people will buy Vasomax once and won't refill if it doesn't work, and that will be that. A lot of play is being given to the recreational use of Viagra and the fact women are using it, too. CNBC has been touting it, constantly, saying that people are using it less for medical than for recreational purposes and that it just increases blood flow. There's some overflow to Muse, because Muse works on some populations that can't be helped by Viagra. But if Vasomax doesn't work, that will be the end of Zonagen. Linda